Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × OTHER_GOV × Prostatic Neoplasms × Clear all

Phase

Phase NA 28 Phase EARLY_PHASE1 4 Phase 2 3 Phase 3 2 Phase 2/3 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 171 INDUSTRY 124 NIH 13 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 7 Breast Neoplasms 7 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Uterine Cervical Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Parasomnias 2 Ovarian Neoplasms 2 Melanoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 HIV Infections 2 Fatigue 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Vitamin D Deficiency 1 Uveal Melanoma 1 Untreated Advanced Non-small Cell Lung Cancer 1 Thrombocytopenia 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Pulmonary Disease, Chronic Obstructive 1 Psoriasis Vulgaris 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1

Interventions

Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡